Company Filing History:
1 out of 34 
1 out of 69 
1 out of 215 
Years Active: 2025
Title: The Innovative Contributions of Marc Billaud
Introduction
Marc Billaud is a notable inventor based in Lyons, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on mitochondrial activity inhibitors that target tumoral metabolism, showcasing his commitment to advancing medical science.
Latest Patents
Marc Billaud holds a patent for "Mitochondrial activity inhibitors targeting tumoral metabolism." This invention relates to compounds of formula (I), wherein specific groups and atoms are utilized to create effective treatments for cancer. The compounds are designed to inhibit mitochondrial activity in tumor cells, potentially leading to improved therapeutic outcomes for patients.
Career Highlights
Throughout his career, Marc Billaud has worked with prestigious institutions such as the Centre Léon Bérard and the Centre National de la Recherche Scientifique (CNRS). His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Marc has collaborated with esteemed colleagues, including Renaud Prudent and Martine Cordier-Bussat. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Marc Billaud's innovative work in developing mitochondrial activity inhibitors represents a significant advancement in cancer treatment. His dedication to research and collaboration with other experts highlights the importance of teamwork in achieving scientific breakthroughs.